Amgen, Inc. vs. Alexion Pharmaceuticals, Inc.
Explore the PTAB proceeding IPR2019-00739 filed by Amgen, Inc. on 2019-02-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-00739
Filing Date
2019-02-28
Accorded Filing Date
2019-02-28
Institution Decision Date
2019-08-30
Last Modified Date
2020-06-01
Proceeding Type
IPR
Termination Date
2020-06-01
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Amgen, Inc.
Represented By
Deborah SterlingPatent Owner / Respondent
Alexion Pharmaceuticals, Inc.
Represented By
Gerald Flattmann, Jr.Patent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28399 | Daniel Boehnen | +1 312-913-0001 |
| 30130 | Bradley Hulbert | +1 312-913-0001 |
| 30243 | Paul Berghoff | +1 312-913-0001 |
| 32565 | Grantland Drutchas | +1 312-913-2121 |
| 32784 | Steven Sarussi | +1 312-913-0001 |
| 35285 | Emily Miao | +1 312-913-0001 |
| 35303 | Kevin Noonan | +1 312-913-0001 |
| 35818 | Lawrence Aaronson | +1 312-913-0001 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,725,504 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,732,149 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,590,189 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2020039221 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,703,809 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 78,307,006 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2009022050 | US Continuation / Sibling | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2007106585 A1 | PCT World Application | View Official Patent → |
| ๐บ๐ธ United States | US 2012023751 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,718,880 B2 | US Continuation / Sibling | View Official Patent → |
Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.
Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.
Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.
Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.
Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.
Amgen, Inc. v. Alexion Pharmaceuticals, Inc.
Amgen Inc. v. Alexion Pharmaceuticals, Inc.